ProCE Banner Activity

Updates on Targeted and Immunotherapies for Advanced Gastric Cancer

Clinical Thought

Get up to date on contemporary treatment for advanced gastric cancer with this expert commentary discussing such topics as biomarker testing, use of targeted therapy and immunotherapy, and management of immune-related adverse events.

Released: May 31, 2022

Expiration: May 30, 2023



Sidharth Anand

Sidharth Anand, MD

Assistant Professor of Medicine                                                                                                                            Division of Hematology - Oncology                                                                                                                              UCLA David Geffen School of Medicine                                                                                                                          Los Angeles, California


This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc; and Merck Sharp & Dohme Corp.



Daiichi Sankyo, Inc.

Target Audience

NPs and PAs in oncology


Sidharth Anand, MD: consultant/advisor/speaker: Curio Science, Signatera.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.


Clinical Thought


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Additional Information

Program Medium

This program has been made available online.